OR WAIT null SECS
Nik Leist’s keynote address will explore the manufacturing of digital medicines at the CPhI North America 2018 conference in Philadelphia, PA, on Wednesday, April 25, 2018.
Within the converged fields of healthcare and technology exist issues of treatment effectiveness and patient adherence. The integration of technology directly into medications, or digital medicines, has created a new category of therapy that has the potential to provide insight into these issues and change the way patients interact with their health.
Nik Leist, senior director of Ingestible Sensor Manufacturing and site leader at Proteus Digital Health, will explore the steps necessary for developing medications with sensors in his keynote address Integrating Silicon with Drugs: Pushing the Boundaries of Pharma Manufacturing with Digital Medicines at the CPhI North America 2018 conference in Philadelphia, PA, on Wednesday, April 25, 2018.
Currently, Nik leads the teams responsible for the end-to-end manufacturing operations for Proteus’ novel ingestible sensor technology. In his previous position at Proteus, Leist contributed to the scaling of Proteus’ campaign model, expanding manufacturing capabilities from 10,000 parts per month to more than one million, according to CPhI North America.
Before joining Proteus, Leist used his background in lean manufacturing to develop and implement a new assembly process for the manufacture of anesthesia systems at Spacelabs Healthcare. He holds a BS degree in Manufacturing Engineering from Western Washington.